Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

Recombinant adenovirus serotype 5 (rAd5) vector-based vaccines are currently being developed for both human immunodeficiency virus type 1 and other pathogens. The potential limitations associated with rAd5 vectors, however, have led to the construction of novel rAd vectors derived from rare Ad serot...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Abbink, Peter, Lemckert, Angelique A. C., Ewald, Bonnie A., Lynch, Diana M., Denholtz, Matthew, Smits, Shirley, Holterman, Lennart, Damen, Irma, Vogels, Ronald, Thorner, Anna R., O'Brien, Kara L., Carville, Angela, Mansfield, Keith G., Goudsmit, Jaap, Havenga, Menzo J. E., Barouch, Dan H.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2007
Teme:
Vaccines and Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1900173/
https://ncbi.nlm.nih.gov/pubmed/17329340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02696-06
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items